Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species

被引:69
|
作者
Gerassimou, C.
Kotanidou, A.
Zhou, Z.
Simoes, D. C. M.
Roussos, C.
Papapetropoulos, A. [1 ]
机构
[1] Univ Athens, Dept Crit Care & Pulm Serv, George P Livanos Lab, Evangelismos Hosp, Athens 10675, Greece
[2] Univ Patras, Dept Pharm, Mol Pharmacol Lab, Patras, Greece
关键词
cGMP; soluble guanylyl cyclase; reactive oxygen species; nitric oxide;
D O I
10.1038/sj.bjp.0707179
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: Superoxide anions produced during vascular disease scavenge nitric oxide ( NO), thereby reducing its biological activity. The aim of the present study was to investigate whether reactive oxygen species ( ROS) have a direct effect on soluble guanylyl cyclase ( sGC) subunit levels and function and to ascertain the mechanism( s) involved. Experimental approach: Rat aortic smooth muscle cells ( RASM) or freshly isolated vessels were exposed to reactive oxygen species ( ROS)-generating agents and sGC subunit expression was determined at the mRNA and/or protein level. cGMP accumulation was also determined in RASM exposed to ROS. Key results: Incubation of smooth muscle cells with H2O2, xanthine/xanthine oxidase ( X/XO) or menadione sodium bisulphite ( MSB) significantly decreased protein levels of alpha 1 and beta 1 subunits of sGC and reduced SNP-induced cGMP formation. Similarly, sGC expression was reduced in freshly isolated vessels exposed to ROS-generating agents. The ROS-triggered inhibition of alpha 1 and beta 1 levels was not blocked by proteasome inhibitors, suggesting that decreased sGC protein was not due to protein degradation through this pathway. Real time RT-PCR analysis demonstrated a 68% reduction in steady state mRNA levels for the alpha 1 subunit following exposure to H2O2. In addition, alpha 1 promoter-driven luciferase activity in RASM decreased by 60% after H2O2 treatment. Conclusion and implications: We conclude that oxidative stress triggers a decrease in sGC expression and activity that results from reduced sGC steady state mRNA levels. Altered sGC expression is expected to contribute to the changes in vascular tone and remodeling observed in diseases associated with ROS overproduction.
引用
收藏
页码:1084 / 1091
页数:8
相关论文
共 50 条
  • [31] Localization of soluble guanylyl cyclase in the superficial dorsal horn
    Ding, JD
    Weinberg, RJ
    JOURNAL OF COMPARATIVE NEUROLOGY, 2006, 495 (06) : 668 - 678
  • [32] Exogenous irritant-induced airway hyperreactivity and inhibition of soluble guanylyl cyclase
    Antosova, Martina
    Strapkova, Anna
    Turcan, Tomas
    BIOLOGICAL RESEARCH FOR NURSING, 2008, 10 (02) : 93 - 101
  • [33] Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme
    Friebe, A
    Schultz, G
    Koesling, D
    EMBO JOURNAL, 1996, 15 (24) : 6863 - 6868
  • [34] Soluble guanylyl cyclase: Molecular basis for ligand selectivity and action in vitro and in vivo
    Wu, Gang
    Sharina, Iraida
    Martin, Emil
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [35] Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase
    Rukoyatkina, Natalia
    Walter, Ulrich
    Friebe, Andreas
    Gambaryan, Stepan
    THROMBOSIS AND HAEMOSTASIS, 2011, 106 (05) : 922 - 933
  • [36] Nucleotidyl Cyclase Activity of Soluble Guanylyl Cyclase α1β1
    Beste, Kerstin Y.
    Burhenne, Heike
    Kaever, Volkhard
    Stasch, Johannes-Peter
    Seifert, Roland
    BIOCHEMISTRY, 2012, 51 (01) : 194 - 204
  • [37] Localization of soluble guanylyl cyclase α-subunit in identified insect neurons
    Elphick, MR
    Jones, IW
    BRAIN RESEARCH, 1998, 800 (01) : 174 - 179
  • [38] Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase
    Klöss, S
    Bouloumié, A
    Mülsch, A
    HYPERTENSION, 2000, 35 (01) : 43 - 47
  • [39] Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase
    Olesen, SP
    Drejer, J
    Axelsson, O
    Moldt, P
    Bang, L
    Nielsen-Kudsk, JE
    Busse, R
    Mülsch, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (02) : 299 - 309
  • [40] Biased activity of soluble guanylyl cyclase: the Janus face of thymoquinone
    Charlotte Detremmerie
    Paul M. Vanhoutte
    Susan Leung
    ActaPharmaceuticaSinicaB, 2017, 7 (04) : 401 - 408